Background. Anaemia is a common complication associated with haemodialysis and is
usually managed by treatment with recombinant human erythropoietin (rHuEPO). However …

Carnitine concentrations were measured in plasma, haemofiltrate, dialysate and urine of
patients on regular dialysis treatment and in normal controls. Patients on haemofiltration and …

Background L-carnitine is an essential compound that facilitates the transport of long-chain
fatty acid across the inner mitochondrial membrane for β-oxidation. However, the effect of L …

Background: Carnitine deficiency is a common condition in patients on maintenance
hemodialysis that contributes to dyslipidemia, anemia, and poor general health in these …

The role of carnitine as a transport molecule to facilitate fatty acid metabolism and energy
production has been studied extensively. Adequate carnitine levels are critical to normal …

L-Carnitine has been reported to have beneficial effects in the reduction of serum
triglycerides and increases high-density lipoprotein cholesterol in hemodialysis patients …

Abstract Background/Aims: There is a growing body of evidence that the long-term
hemodialysis (HD) treatment leads to disturbances of carnitine homeostasis but the results …

Chronic hemodialysis (HD) may lead to losses of carnitine from plasma and muscle. Plasma
carnitine does not reflect the body content of carnitine. The purpose of this study was the …

Patients receiving hemodialysis also manifest gastrointestinal symptoms, such as
constipation, caused by restriction of water intake and the loss of body water balance …

Objective Patients on dialysis are in a chronic carnitine‐deficient state. This condition may
be associated with abnormalities in fatty acid and organic acid metabolism; however, the …